- Home
- YJ vs AYTU Comparison
YJ vs AYTU Comparison
Compare YJ & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YJ
- AYTU
- Stock Information
- Founded
- YJ 2015
- AYTU N/A
- Country
- YJ China
- AYTU United States
- Employees
- YJ N/A
- AYTU N/A
- Industry
- YJ Other Specialty Stores
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- YJ Consumer Discretionary
- AYTU Health Care
- Exchange
- YJ Nasdaq
- AYTU Nasdaq
- Market Cap
- YJ 8.8M
- AYTU 8.3M
- IPO Year
- YJ 2019
- AYTU N/A
- Fundamental
- Price
- YJ $1.60
- AYTU $1.25
- Analyst Decision
- YJ
- AYTU
- Analyst Count
- YJ 0
- AYTU 0
- Target Price
- YJ N/A
- AYTU N/A
- AVG Volume (30 Days)
- YJ 15.8K
- AYTU 26.1K
- Earning Date
- YJ 06-10-2025
- AYTU 05-14-2025
- Dividend Yield
- YJ N/A
- AYTU N/A
- EPS Growth
- YJ N/A
- AYTU N/A
- EPS
- YJ N/A
- AYTU N/A
- Revenue
- YJ $57,219,520.00
- AYTU $77,232,000.00
- Revenue This Year
- YJ N/A
- AYTU N/A
- Revenue Next Year
- YJ N/A
- AYTU $8.14
- P/E Ratio
- YJ N/A
- AYTU N/A
- Revenue Growth
- YJ N/A
- AYTU N/A
- 52 Week Low
- YJ $1.42
- AYTU $0.95
- 52 Week High
- YJ $3.46
- AYTU $3.45
- Technical
- Relative Strength Index (RSI)
- YJ 47.30
- AYTU 57.32
- Support Level
- YJ $1.37
- AYTU $1.20
- Resistance Level
- YJ $1.78
- AYTU $1.31
- Average True Range (ATR)
- YJ 0.15
- AYTU 0.11
- MACD
- YJ -0.00
- AYTU 0.02
- Stochastic Oscillator
- YJ 32.01
- AYTU 53.19
About YJ Yunji Inc. American Depository Shares
Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in China.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.